Comprehensive Pan-Cancer Analysis Reveals the Role of UHRF1-Mediated DNA Methylation and Immune Infiltration in Renal Cell Carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive Pan-Cancer Analysis Reveals the Role of UHRF1-Mediated DNA Methylation and Immune Infiltration in Renal Cell Carcinoma
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2022, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2022-05-24
DOI
10.1155/2022/3842547
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
- (2021) Kelly E. Craven et al. Scientific Reports
- UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE
- (2021) Limin Liu et al. Clinical Epigenetics
- Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
- (2020) Ulla Kring Hansen et al. Frontiers in Immunology
- UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma
- (2020) Zhenbo Tu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT
- (2020) Jun-ichi Kawada et al. Journal of Cardiology
- Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population
- (2020) Jungyo Suh et al. BMC Urology
- Tumor mutational burden (TMB) standardization initiatives: Recommendations for consistent TMB assessment in clinical samples to guide immunotherapy treatment decisions
- (2019) Albrecht Stenzinger et al. GENES CHROMOSOMES & CANCER
- Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies
- (2019) Busheng Xue et al. OncoTargets and Therapy
- UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer
- (2019) Qiangsheng Hu et al. CANCER LETTERS
- Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties
- (2019) Xiangqian Kong et al. CANCER CELL
- UHRF1 is regulated by miR‐124‐3p and promotes cell proliferation in intrahepatic cholangiocarcinoma
- (2019) Mengxuan Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP
- (2019) Dian Jiao et al. ONCOGENE
- Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway
- (2019) Yang Liu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Epidrugs: targeting epigenetic marks in cancer treatment
- (2019) Cristiana Libardi Miranda Furtado et al. Epigenetics
- Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
- (2019) Pengfei Zhao et al. Journal of Hematology & Oncology
- A disparate role of RP11-424C20.2/UHRF1 axis through control of tumor immune escape in liver hepatocellular carcinoma and thymoma
- (2019) Jue Yang et al. Aging-US
- Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
- (2019) Li Liu et al. CLINICAL CANCER RESEARCH
- Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
- (2019) Ibrahim Halil Sahin et al. BRITISH JOURNAL OF CANCER
- Correlations between microsatellite instability and the biological behaviour of tumours
- (2019) Guang Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
- (2018) Linglong Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Analysis of DNA methylation in cancer: location revisited
- (2018) Alexander Koch et al. Nature Reviews Clinical Oncology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- A Bifunctional Role for the UHRF1 UBL Domain in the Control of Hemi-methylated DNA-Dependent Histone Ubiquitylation
- (2018) Paul A. DaRosa et al. MOLECULAR CELL
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma
- (2017) Xincheng Liu et al. Oncotarget
- The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer
- (2017) Waseem Ashraf et al. Oncotarget
- Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
- (2016) Mahmoud Alhosin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells
- (2016) Ting-Ting Ge et al. Journal of Ovarian Research
- UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
- (2016) Kenichi Nakamura et al. Oncotarget
- Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p
- (2016) Zofia Wotschofsky et al. PLoS One
- The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma
- (2015) Han Zhuo et al. MOLECULAR CARCINOGENESIS
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Conserved linker regions and their regulation determine multiple chromatin-binding modes of UHRF1
- (2015) Maria Tauber et al. Nucleus
- Conserved linker regions and their regulation determine multiple chromatin-binding modes of UHRF1
- (2015) Maria Tauber et al. Nucleus
- Upregulated UHRF1 Promotes Bladder Cancer Cell Invasion by Epigenetic Silencing of KiSS1
- (2014) Yu Zhang et al. PLoS One
- Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis
- (2013) Christian Bronner et al. BIOCHEMICAL PHARMACOLOGY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1
- (2012) Mayada Achour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients
- (2012) Yao Geng et al. CANCER SCIENCE
- UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis
- (2011) Amy L. Tien et al. BIOCHEMICAL JOURNAL
- UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
- (2009) Wei Jin et al. BREAST CANCER RESEARCH AND TREATMENT
- Epigenetic inheritance during the cell cycle
- (2009) Aline V. Probst et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix
- (2008) Hideharu Hashimoto et al. NATURE
- Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism
- (2008) Kyohei Arita et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation